News
FDA Advisory Group Permits Bluebird Gene Therapy Amid Risks
Bluebird bio has persuaded an expert committee that the benefits of its gene therapy possibility, eli-cel, exceed the risks, at least in certain patients,...
News
Alnylam Shares Findings On Delivering siRNA Beyond The Liver
Alnylam has outlined their strategy for delivering siRNA to the central nervous system and other organs outside of the liver. The RNA specialist detailed...
News
With Keytruda, Merck Sees 80 Plus Eligible Oncology Wins
Merck & Co. was not at all a prominent oncology player before the advent of Keytruda. The New Jersey drugmaker wants to consolidate its supremacy...
News
Lunsumio, Blood Cancer Drug By Roche Gets Global Approval
Roche is exploring new products to refill its blood cancer armoury after Rituxan's patent expiration. Swiss pharma is launching a novel bispecific lymphoma medicine...
News
Each Patient In The Clinical Study Sees The Cancer Vanish
It was a small study, with only 18 rectal cancer sufferers taking the same medicine.
However, the outcomes were astounding. Every single patient's cancer vanished,...
Drug Research
New Drug Mix From ICR And The Royal Marsden Shows Promise
The findings of a phase 1 trial examining a medication mixture targeting multiple mutant variants of cancer's 'death star' protein have been released by...
News
Thermo Fisher Scientific Recognizes Tandem Mass Tag Grant Award Winners
Thermo Fisher Scientific, the world leader in serving science, announces the winners of the 2022 Thermo Scientific Tandem Mass Tag (TMT) Research Award. Now...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read